Last $8.89 USD
Change Today -0.19 / -2.09%
Volume 136.0K
VSTM On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

verastem inc (VSTM) Snapshot

Open
$9.03
Previous Close
$9.08
Day High
$9.33
Day Low
$8.82
52 Week High
07/11/13 - $18.82
52 Week Low
04/15/14 - $8.20
Market Cap
229.6M
Average Volume 10 Days
175.0K
EPS TTM
$-1.90
Shares Outstanding
25.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VERASTEM INC (VSTM)

Related News

No related news articles were found.

verastem inc (VSTM) Related Businessweek News

No Related Businessweek News Found

verastem inc (VSTM) Details

Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the focal adhesion kinase (FAK) and the PI3K/mTOR signaling pathways. The company’s lead FAK inhibitor, VS-6063, is in a registration-directed trial in patients with mesothelioma; a Phase Ib trial in combination with weekly paclitaxel for patients with ovarian cancer; a Phase II study in patients with non-small cell lung cancer; and a Phase I trial in Japan in patients with solid tumors. It is also developing FAK inhibitor, VS-4718; and dual mTORC1/2 and PI3K inhibitor, VS-5584, which are in Phase I clinical trials in patients with advanced cancers. The company’s product candidates target CSCs that have been implicated in aggressive cancers, metastasis, and chemotherapeutic resistance. Verastem, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

30 Employees
Last Reported Date: 03/6/14
Founded in 2010

verastem inc (VSTM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $443.8K
Co-Founder, Executive Chairman and Chairman o...
Total Annual Compensation: --
Chief Medical Officer
Total Annual Compensation: $350.0K
Chief Business Officer
Total Annual Compensation: $314.7K
Compensation as of Fiscal Year 2013.

verastem inc (VSTM) Key Developments

Verastem to Move Headquarters to Needham from Cambridge

Verastem has leased a 15,000-square-foot space in Needham for a new corporate headquarters and laboratory. The company - which is now based at 215 First St. in Cambridge's Kendall Square - signed an agreement earlier this week for a five-year lease starting immediately. The company confirmed that the company is moving its corporate headquarters and laboratories to Needham 'later this year'. The company believed to be responsible for relapse - will initially pay $493,000 per year for the space at 117 Kendrick St. The rent will increase every year to a maximum of $554,000 in the fifth year. Verastem paid a $203,000 deposit on the space. The landlord will be Intercontinental Fund III.

Verastem, Inc. Presents at Boston Biotech BD Boston Conference, Mar-25-2014 through Mar-26-2014

Verastem, Inc. Presents at Boston Biotech BD Boston Conference, Mar-25-2014 through Mar-26-2014. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Presentation Date & Speakers: Mar-25-2014, Christoph H. Westphal, Co-Founder, Executive Chairman and Chairman of Governance & Nominating Committee, Daniel W. Paterson, Chief Business Officer. Mar-26-2014, Christoph H. Westphal, Co-Founder, Executive Chairman and Chairman of Governance & Nominating Committee, Daniel W. Paterson, Chief Business Officer.

Verastem, Inc. Appoints Timothy J. Barberich to its Board of Directors

Verastem, Inc. announced the appointment of Timothy J. Barberich to its Board of Directors. Mr. Barberich founded Sepracor, Inc. in 1984 and served as CEO and Chairman for more than 20 years. Prior to founding Sepracor, Mr. Barberich spent 10 years as a senior executive at Millipore Corporation.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSTM:US $8.89 USD -0.19

VSTM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VSTM.
View Industry Companies
 

Industry Analysis

VSTM

Industry Average

Valuation VSTM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERASTEM INC, please visit www.verastem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.